Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot comparative study of oral moxifloxacin vs levofloxacin sequential therapy in immunocompetent adults with community-acquired pneumonia
2006-006842-33Phase 4Active
- Sponsor
- Fundación Interhospitalaria de Investigación Cardiovascular
- Start
- Mar 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of moxifloxacin and levofloxacin in community-acquired pneumonia (CAP) (2 arms), sponsored by Fundación Interhospitalaria de Investigación Cardiovascular. Primary endpoints: Cost-effectiveness (early discharge and healthcare cost savings) and Clinical efficacy. Started Mar 2010; status: active.
02
Drugs
moxifloxacinlevofloxacin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2006-006842-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006842-33.